// App-Quantinova.ai

AB1376 : ADHERENCE TO SUBCUTANEOUS VS. ORAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS

Researchers

Presenter

  • M. Bergman

Principal Investigators

  • Y. Bao

  • R. Ayyagari

  • P.M. Mulani

Medical Centers

  • Taylor Hospital, Ridley Park, PA

Locations

  • United States

Companies

  • Abbott

  • Analysis Group, Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • HWA-486

  • Adalimumab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved